Sewoon Medical Co., Ltd (KOSDAQ:100700)

Sewoon Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Other Revenue	-	-	-0	-	-	-0
Revenue	59,873	60,151	68,247	60,116	62,579	63,729
Revenue Growth (YoY)	-10.91%	-11.86%	13.53%	-3.94%	-1.80%	-4.70%
Cost of Revenue	38,462	37,963	40,689	37,896	37,522	40,005
Gross Profit	21,411	22,188	27,557	22,220	25,057	23,725
Selling, General & Admin	9,553	9,468	9,330	8,734	8,466	8,344
Research & Development	510.33	510.42	468.21	505.09	427.87	321.38
Operating Expenses	10,923	10,811	10,637	10,033	9,671	9,828
Operating Income	10,489	11,377	16,920	12,187	15,386	13,897
Interest Expense	-39.71	-36.63	-36.08	-35.81	-31.47	-31.63
Interest & Investment Income	2,265	2,331	1,969	736.18	172.83	133.32
Currency Exchange Gain (Loss)	1,149	1,597	357.41	702.87	1,035	-578.91
Other Non Operating Income (Expenses)	68	73.35	69.67	38.25	67.05	159.15
EBT Excluding Unusual Items	13,931	15,342	19,280	13,629	16,630	13,579
Gain (Loss) on Sale of Assets	293.44	279.54	17.79	2.2	-0.67	-8.81
Asset Writedown	-	-	-	-2	-2.96	-233.53
Pretax Income	14,225	15,621	19,298	13,629	16,626	13,337
Income Tax Expense	2,736	3,046	3,824	2,990	3,864	2,782
Earnings From Continuing Operations	11,488	12,575	15,474	10,639	12,762	10,555
Earnings From Discontinued Operations	-	-	-	-	-	286.25
Net Income to Company	11,488	12,575	15,474	10,639	12,762	10,841
Minority Interest in Earnings	-351.78	-412.61	-517.02	-232.69	-480.5	-345.26
Net Income	11,137	12,163	14,957	10,406	12,282	10,496
Net Income to Common	11,137	12,163	14,957	10,406	12,282	10,496
Net Income Growth	-25.00%	-18.68%	43.73%	-15.27%	17.02%	10.76%
Shares Outstanding (Basic)	43	43	43	43	43	43
Shares Outstanding (Diluted)	43	43	43	43	43	43
Shares Change (YoY)	0.16%	-	-	-	-	-
EPS (Basic)	257.01	280.95	345.50	240.38	283.70	242.44
EPS (Diluted)	257.01	280.95	345.50	240.38	283.70	242.44
EPS Growth	-24.96%	-18.68%	43.73%	-15.27%	17.02%	10.76%
Free Cash Flow	10,172	11,750	21,127	7,128	19,244	16,978
Free Cash Flow Per Share	234.75	271.42	488.02	164.65	444.53	392.19
Dividend Per Share	60.000	60.000	70.000	60.000	50.000	50.000
Dividend Growth	-14.29%	-14.29%	16.67%	20.00%	-	-
Gross Margin	35.76%	36.89%	40.38%	36.96%	40.04%	37.23%
Operating Margin	17.52%	18.91%	24.79%	20.27%	24.59%	21.81%
Profit Margin	18.60%	20.22%	21.92%	17.31%	19.63%	16.47%
Free Cash Flow Margin	16.99%	19.54%	30.96%	11.86%	30.75%	26.64%
EBITDA	13,971	14,857	20,568	16,075	19,222	17,581
EBITDA Margin	23.33%	24.70%	30.14%	26.74%	30.72%	27.59%
D&A For EBITDA	3,482	3,480	3,648	3,888	3,836	3,684
EBIT	10,489	11,377	16,920	12,187	15,386	13,897
EBIT Margin	17.52%	18.91%	24.79%	20.27%	24.59%	21.81%
Effective Tax Rate	19.24%	19.50%	19.82%	21.94%	23.24%	20.86%
Advertising Expenses	-	294.06	233.54	186.34	76.21	29.71

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.